Metastat Insights
Back to Healthcare

Drug Screening Market

Drug Screening Market By Product Type (Immunoassay Kits, Chromatography Devices, Mass Spectrometry Systems, Rapid Testing Devices, Sample Collection Devices, Laboratory Reagents, and Consumables), By Testing Method (Urine Testing, Saliva Testing, Blood Testing, Hair Testing, and Sweat Testing), By Application (Workplace Testing, Clinical Testing, Forensic Testing, Sports Anti-Doping Programs, Pre-employment Screening, and Post-Accident Screening), By End-User (Healthcare Providers, Workplaces, Government Agencies, Educational Institutions, Rehabilitation Centers, and Pharmaceutical Companies), Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Report ID

MSI-3323

Published

January 18, 2026

Pages

256 Pages

Format
Market Size 2026
Leadership Strategies
Key Trends
Market Size 2033

Report Details

Comprehensive Market Analysis And Insights

End of Report Overview

Frequently Asked Questions

Find answers to common questions about this report

Global Drug Screening market is valued at $10,535.59 million in 2025.

Global Drug Screening market is estimated to grow with a CAGR of 16.6% from 2025 to 2032.

Global Drug Screening market is estimated to reach $30,280.68 million by 2032.

Top players operating in the Drug Screening industry includes Abbott Laboratories, Quest Diagnostics Incorporated, and F. Hoffmann-La Roche Ltd.

Related Reports

Explore related market intelligence reports worth reading alongside this one.